Table 1.
Association between TAF1D expression and clinicopathological parameters in OS samples based on TARGET database
| Clinicopathological | TAF1D | expression | t-test | ||
|---|---|---|---|---|---|
| parameters | N | M | SD | t-value | p-value |
| Gender | |||||
| Female | 37 | 2.965 | 0.747 | 0.694 | 0.489 |
| Male | 47 | 2.861 | 0.625 | ||
| Age | |||||
| <18 | 66 | 2.944 | 0.669 | -0.976 | 0.332 |
| ≥18 | 18 | 2.768 | 0.716 | ||
| Recurrence | |||||
| No | 65 | 2.867 | 0.645 | 0.991 | 0.325 |
| Yes | 19 | 3.042 | 0.789 | ||
| Metastasis | |||||
| No | 63 | 2.869 | 0.706 | 1.128 | 0.263 |
| Yes | 21 | 3.018 | 0.594 | ||
| Survival state | |||||
| Alive | 57 | 2.745 | 0.653 | 3.21 | 0.002 |
| Dead | 27 | 3.237 | 0.624 | ||
| Primary tumor site | |||||
| Femur/Tibia | 76 | 2.927 | 0.667 | 0.846 | 0.400 |
| Others | 8 | 2.713 | 0.815 |
TARGET: Therapeutically Applicable Research to Generate Effective Treatments; M: mean; N: number; OS: osteosarcoma; SD: standard deviation.